Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure... see more

Recent & Breaking News (TSXV:AVCR)

VANC Pharmaceuticals Announces Non Brokered Private Placement

MarketWire Canada January 30, 2017

VANC Pharmaceuticals Announces Intent To Acquire HealthTab

MarketWire Canada December 5, 2016

VANC Pharmaceuticals Receives Health Canada Approval for Van-Fer Tablets and Capsules

MarketWire Canada June 21, 2016

VANC Pharmaceuticals Signs Definitive Agreement for Exclusive In-License on a CAD $150M Generic Molecule and soon to be Off Patent Molecule

MarketWire Canada June 20, 2016

Vanc Pharmaceuticals Announces Launch of New OTC Product and Provides Update on Sales Force Ramp Up

MarketWire Canada May 2, 2016

Magellan Securityholders Approve Business Combination With Anfield Nickel Corp.

MarketWire Canada May 2, 2016

VANC Pharmaceuticals Announces Corporate Update and Launch of Hema-Fer

Marketwired March 7, 2016

VANC Pharmaceuticals Recognized as the Top Clean Technology & Life Sciences Company on the 2016 TSX Venture 50(TM)

Marketwired January 25, 2016

VANC Pharmaceuticals Appointment of Mr. David Hall to Its Board of Directors

Marketwired January 21, 2016

Vanc Pharmaceuticals Launches First OTC Product in British Columbia

Marketwired December 7, 2015

VANC Pharmaceuticals Commences Commercialization in Ontario

Marketwired October 22, 2015

VANC Pharmaceuticals Announces Listing of Products on Six Provincial Formularies in Canada

Marketwired October 7, 2015

Vanc Pharmaceuticals Provides Corporate Update

Marketwired September 22, 2015

Promo Watch: Moseda Technologies (V.MSD) doubles in two days

Chris Parry August 5, 2015

VANC Pharmaceuticals Commences Commercialization in British Columbia and Receives $1,095,728 in Proceeds From Warrant and Option Exercises

Marketwired July 8, 2015

VANC Pharmaceuticals Announces Appointment of Mr. Bob Rai to its Board of Directors

Marketwired June 5, 2015

VANC Pharmaceuticals Provides Corporate Update

Stockhouse.com May 19, 2015

VANC Pharmaceuticals (V.NPH) receives approvals on 5 new generic molecules

Stockhouse Editorial May 4, 2015

IIROC Trade Resumption - Vanc Pharmaceuticals Inc.

Newsfile May 4, 2015

IIROC Trading Resumption - NPH

Canada NewsWire May 4, 2015